Mechanisms regulating glucagon release and its integrated actions within the liver- α-cell axis
File(s) 427021d8-7226-4f91-9147-061518a7a823.pdf (632.43 KB)
Accepted version
Author(s)
Tomas Catala, Alejandra
Type
Journal Article
Abstract
Glucagon is increasingly recognised as a central regulator of metabolic homeostasis rather than simply the counter-regulatory hormone opposing insulin. Beyond its classical role in maintaining blood glucose homeostasis during fasting, glucagon further integrates amino acid and lipid metabolism through coordinated communication between the pancreatic islet and the liver. Recent advances have substantially expanded our understanding of the mechanisms governing glucagon secretion, revealing that pancreatic α-cells integrate intrinsic nutrient sensing with complex paracrine, autocrine, hormonal and neural inputs to fine-tune glucagon release according to metabolic demand. Concurrently, the identification of the liver-α-cell axis has established hepatic amino acid metabolism as a key determinant of α-cell function, linking glucagon signalling to amino acid homeostasis, α-cell proliferation and metabolic adaptation. In this review, we summarise our current understanding of the molecular and physiological mechanisms regulating glucagon secretion, including glucose sensing, intra-islet signalling, nutrient-specific regulation and neuroendocrine control. We then discuss glucagon receptor signalling in the liver and its integrated effects on glucose production, lipid metabolism, amino acid catabolism and ureagenesis, highlighting the liver-α-cell feedback loop as a central metabolic homeostasis mechanism. Finally, we examine how disruption of these pathways contributes to obesity, type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease and discuss the emergence of glucagon-based dual-and triple-receptor agonists that exploit the beneficial metabolic actions of glucagon while balancing its hyperglycaemic effects. Improved understanding of glucagon biology and pancreas-liver communication is reshaping therapeutic strategies for metabolic diseases.
Date Acceptance
2026-10-13
Citation
Frontiers in Endocrinology
ISSN
1664-2392
Publisher
Frontiers Media S.A.
Journal / Book Title
Frontiers in Endocrinology
Copyright Statement
Copyright This paper is embargoed until publication. Once published the Version of Record (VoR) will be available on immediate open access.
License URL
Publication Status
Accepted
